相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
Kristian Reich et al.
LANCET (2021)
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
Kenneth B Gordon et al.
LANCET (2021)
Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets
Jaehwan Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Bimekizumab versus Adalimumab in Plaque Psoriasis
R. B. Warren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Bimekizumab versus Secukinumab in Plaque Psoriasis
Kristian Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scripts
John J. Cole et al.
BMC BIOINFORMATICS (2021)
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial
Sophie Glatt et al.
JAMA DERMATOLOGY (2021)
Presence, function, and regulation of IL-17F-expressing human CD4+ T cells
Lachrissa A. Burns et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
Christopher T Ritchlin et al.
LANCET (2020)
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24
Wai Po Chong et al.
IMMUNITY (2020)
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis
Frank Penkava et al.
NATURE COMMUNICATIONS (2020)
Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling
Suzanne Cole et al.
FRONTIERS IN IMMUNOLOGY (2020)
Helper T cell differentiation
Jordy Saravia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Evaluating STAT5 Phosphorylation as a Mean to Assess T Cell Proliferation
Michael Bitar et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Kim A. Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation
Sophie Glatt et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis
Frank Kolbinger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
Are interleukin-15 and-22 a new pathogenic factor in pustular palmoplantar psoriasis?
Aleksandra Lesiak et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
Lisa G. M. van Baarsen et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Improved workflows for high throughput library preparation using the transposome-based nextera system
Sarah Lamble et al.
BMC BIOTECHNOLOGY (2013)
The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells
Juraj Adamik et al.
CYTOKINE (2013)
Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation
Andrew C. Melton et al.
PLOS ONE (2013)
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Caryn S. Ross-Innes et al.
NATURE (2012)
Induction and molecular signature of pathogenic TH17 cells
Youjin Lee et al.
NATURE IMMUNOLOGY (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
Xiang-Ping Yang et al.
NATURE IMMUNOLOGY (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Lydia Durant et al.
IMMUNITY (2010)
Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens
Meredith M. Curtis et al.
IMMUNOLOGY (2009)
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Antonella Di Cesare et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Structure and signalling in the IL-17 receptor family
Sarah L. Gaffen
NATURE REVIEWS IMMUNOLOGY (2009)
Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
Camilla Jandus et al.
ARTHRITIS AND RHEUMATISM (2008)
The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex
Jill F. Wright et al.
JOURNAL OF IMMUNOLOGY (2008)
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice
Laura McKinley et al.
JOURNAL OF IMMUNOLOGY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment
Spencer C. Liang et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells
Zhi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding
SG Hymowitz et al.
EMBO JOURNAL (2001)
分享论文
